Klaviyo, Inc. (NYSE:KVYO – Get Free Report) saw a large decline in short interest in November. As of November 30th, there was short interest totalling 5,800,000 shares, a decline of 24.6% from the November 15th total of 7,690,000 shares. Based on an average trading volume of 1,200,000 shares, the days-to-cover ratio is presently 4.8 days. Approximately 11.1% of the company’s shares are short sold.
Klaviyo Stock Performance
KVYO stock traded down $0.18 during mid-day trading on Friday, hitting $39.06. The company had a trading volume of 910,807 shares, compared to its average volume of 1,180,864. The firm has a market cap of $10.53 billion, a PE ratio of -217.00 and a beta of 0.97. Klaviyo has a 12 month low of $21.26 and a 12 month high of $41.00. The stock’s fifty day moving average price is $37.41 and its two-hundred day moving average price is $31.10.
Klaviyo (NYSE:KVYO – Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.04. Klaviyo had a negative net margin of 5.23% and a positive return on equity of 0.86%. The company had revenue of $235.09 million for the quarter, compared to analysts’ expectations of $226.33 million. During the same quarter in the previous year, the firm posted ($1.24) EPS. Klaviyo’s revenue was up 33.7% on a year-over-year basis. Equities analysts anticipate that Klaviyo will post 0.03 earnings per share for the current year.
Analyst Ratings Changes
Read Our Latest Stock Analysis on Klaviyo
Insider Activity
In other Klaviyo news, CTO Allen Chaves sold 130,000 shares of the stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $31.85, for a total value of $4,140,500.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Amanda Whalen sold 1,050 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $40.07, for a total value of $42,073.50. Following the completion of the sale, the chief financial officer now directly owns 395,616 shares of the company’s stock, valued at $15,852,333.12. This trade represents a 0.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 275,764 shares of company stock worth $9,383,087 in the last quarter. 53.24% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the company. Advisors Asset Management Inc. raised its position in shares of Klaviyo by 145.6% in the third quarter. Advisors Asset Management Inc. now owns 1,363 shares of the company’s stock valued at $48,000 after purchasing an additional 808 shares during the period. nVerses Capital LLC bought a new stake in Klaviyo during the 3rd quarter valued at $53,000. West Tower Group LLC purchased a new stake in shares of Klaviyo during the third quarter worth $177,000. Victory Capital Management Inc. bought a new position in shares of Klaviyo in the third quarter worth $208,000. Finally, SG Americas Securities LLC purchased a new position in shares of Klaviyo in the second quarter valued at $236,000. Hedge funds and other institutional investors own 45.43% of the company’s stock.
About Klaviyo
Klaviyo, Inc, a technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers Klaviyo, a cloud-native platform for data store, segmentation engine, campaigns and flows, and messaging infrastructure.
Featured Articles
- Five stocks we like better than Klaviyo
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- There Are Different Types of Stock To Invest In
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Quiet Period Expirations Explained
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Klaviyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klaviyo and related companies with MarketBeat.com's FREE daily email newsletter.